Dr. Elyse Watkins
The purpose of this article is to review the use of sub-anesthetic dosing of ketamine for resolution of suicidal ideation (SI) in emergency departments (ED). Based on properties of esketamine being a rapid-acting antidepressant for patients with treatment-resistant depression (TRD), one can extrapolate that improving TRD will have a direct correlation on the decrease of SI.1 In patients with TRD and SI, the use of sub-anesthetic intravenous use of ketamine has shown to improve both. Since Esketamine approval for TRD, there is promise that similar results could be achieved with subanesthetic doses of ketamine for acute SI.
"Subanesthetic Ketamine for Suicidal Ideation Resolution in Emergency Departments,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 64.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss4/64
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.